ANGPT1 and COVID-19: Diabetes, hypertension, and a history of cardiovascular events leading to RAS dysregulation and ACE2 deficiency represent risk factors for increased disease severity in COVID-19 due to the imbalance between the Ang II-AT1R pathway and its ACE2-Ang1–7 counter-regulatory arm [6].